Zevra Therapeutics (ZVRA) Operating Leases (2019 - 2026)
Zevra Therapeutics (ZVRA) posted Operating Leases of $870,000 for Q2 2026, down 17.8% from $1.06 million a year earlier but up 17.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Zevra Therapeutics' Operating Leases came in at $859,000, up 130.9% from FY2024.
- Annual Operating Leases shows a five-year compound annual growth rate of -11.6% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Operating Leases was $372,000 in FY2024 (-18.4%), $456,000 in FY2023 (-45.9%), $843,000 in FY2022 (-31.6%) and $1.23 million in FY2021 (-22.4%).
- Quarterly Operating Leases has run from a low of $372,000 in Q4 2024 to a high of $1.32 million in Q3 2021 over five years.
- On a year-over-year basis, Operating Leases increased in four of the last eight quarters, with growth averaging 38.9%.
- The strongest year-over-year quarter for Operating Leases in the past five years was Q4 2025, with growth of 130.9%; the weakest was Q3 2023, with a decline of 45.9%.
- According to Business Quant data, Operating Leases for the three prior quarters was $741,000 (Q1 2026), $859,000 (Q4 2025) and $966,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Zevra Therapeutics | 612.56 Mn | -200.15 Mn | 38.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 870,000.00 |
| Mar 31, 2026 | 741,000.00 |
| Dec 31, 2025 | 859,000.00 |
| Sep 30, 2025 | 966,000.00 |
| Jun 30, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.16 Mn |
| Dec 31, 2024 | 372,000.00 |
| Sep 30, 2024 | 483,000.00 |
| Jun 30, 2024 | 544,000.00 |
| Mar 31, 2024 | 705,000.00 |
| Dec 31, 2023 | 456,000.00 |
| Sep 30, 2023 | 517,000.00 |
| Jun 30, 2023 | 627,000.00 |
| Mar 31, 2023 | 736,000.00 |
| Dec 31, 2022 | 843,000.00 |
| Sep 30, 2022 | 956,000.00 |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 1.14 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 1.32 Mn |
API Access
Zevra Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();